| Year |
Citation |
Score |
| 2018 |
Asbach B, Kibler KV, Köstler J, Perdiguero B, Yates NL, Stanfield-Oakley S, Tomaras GD, Kao SF, Foulds KE, Roederer M, Seaman MS, Montefiori DC, Parks R, Ferrari G, Forthal DN, ... ... Self SG, et al. Priming with a potent HIV-1 DNA vaccine frames the quality of immune responses prior to a poxvirus and protein boost. Journal of Virology. PMID 30429343 DOI: 10.1128/Jvi.01529-18 |
0.373 |
|
| 2018 |
Nemes E, Geldenhuys H, Rozot V, Rutkowski KT, Ratangee F, Bilek N, Mabwe S, Makhethe L, Erasmus M, Toefy A, Mulenga H, Hanekom WA, Self SG, Bekker LG, Ryall R, et al. Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination. The New England Journal of Medicine. 379: 138-149. PMID 29996082 DOI: 10.1056/Nejmoa1714021 |
0.318 |
|
| 2017 |
Moodie Z, Juraska M, Huang Y, Zhuang Y, Fong Y, Carpp LN, Self SG, Chambonneau L, Small R, Jackson N, Noriega F, Gilbert PB. Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin America. The Journal of Infectious Diseases. PMID 29194547 DOI: 10.1093/Infdis/Jix609 |
0.351 |
|
| 2017 |
García-Arriaza J, Perdiguero B, Heeney JL, Seaman MS, Montefiori DC, Yates NL, Tomaras GD, Ferrari G, Foulds KE, Roederer M, Self SG, Borate B, Gottardo R, Phogat S, Tartaglia J, et al. HIV/AIDS vaccine candidates based on replication-competent recombinant poxvirus NYVAC-C-KC expressing trimeric gp140 and Gag-derived VLPs or lacking the viral molecule B19 that inhibits type I interferon activate relevant HIV-1-specific B and T cell immune functions in non-human primates. Journal of Virology. PMID 28179536 DOI: 10.1128/Jvi.02182-16 |
0.365 |
|
| 2016 |
Asbach B, Kliche A, Köstler J, Perdiguero B, Esteban M, Jacobs BL, Montefiori DC, LaBranche CC, Yates NL, Tomaras GD, Ferrari G, Foulds KE, Roederer M, Landucci G, Forthal DN, ... ... Self SG, et al. Streamlining Heterologous DNA-Prime and NYVAC/Protein-Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens. Journal of Virology. PMID 26865719 DOI: 10.1128/Jvi.03135-15 |
0.373 |
|
| 2015 |
Walsh SR, Moodie Z, Fiore-Gartland AJ, Morgan C, Wilck MB, Hammer SM, Buchbinder SP, Kalams SA, Goepfert PA, Mulligan MJ, Keefer MC, Baden LR, Swann EM, Grant S, Ahmed H, ... ... Self SG, et al. Vaccination with heterologous HIV envelope sequences and heterologous adenovirus vectors increases T cell responses to conserved regions (HVTN 083). The Journal of Infectious Diseases. PMID 26475930 DOI: 10.1093/Infdis/Jiv496 |
0.39 |
|
| 2015 |
Behr M, Ellis R, Ernst J, Evans T, Flynn J, Hatherill M, Hoft D, Lalvani A, McShane H, Nardell E, Ordway D, Ramanathan R, Ruhwald M, Schlesinger L, Self S, et al. Developing vaccines to prevent sustained infection with Mycobacterium tuberculosis: Conference proceedings. National Institute of Allergy and Infectious Diseases, Rockville, Maryland USA, November 7, 2014. Vaccine. 33: 3056-3064. DOI: 10.1016/J.Vaccine.2015.03.061 |
0.318 |
|
| 2014 |
Hawn TR, Day TA, Scriba TJ, Hatherill M, Hanekom WA, Evans TG, Churchyard GJ, Kublin JG, Bekker LG, Self SG. Tuberculosis vaccines and prevention of infection. Microbiology and Molecular Biology Reviews : Mmbr. 78: 650-71. PMID 25428938 DOI: 10.1128/Mmbr.00021-14 |
0.351 |
|
| 2014 |
Qin LX, Breeden L, Self SG. Finding gene clusters for a replicated time course study. Bmc Research Notes. 7: 60. PMID 24460656 DOI: 10.1186/1756-0500-7-60 |
0.472 |
|
| 2013 |
Gantt S, Yao L, Kollmann TR, Casper C, Zhang J, Self SG. Implications of Age-Dependent Immune Responses to Enterovirus 71 Infection for Disease Pathogenesis and Vaccine Design. Journal of the Pediatric Infectious Diseases Society. 2: 162-70. PMID 26619463 DOI: 10.1093/Jpids/Pit017 |
0.346 |
|
| 2013 |
Hertz T, Ahmed H, Friedrich DP, Casimiro DR, Self SG, Corey L, McElrath MJ, Buchbinder S, Horton H, Frahm N, Robertson MN, Graham BS, Gilbert P. HIV-1 vaccine-induced T-cell responses cluster in epitope hotspots that differ from those induced in natural infection with HIV-1. Plos Pathogens. 9: e1003404. PMID 23818843 DOI: 10.1371/Journal.Ppat.1003404 |
0.413 |
|
| 2012 |
Kaufman DR, Li F, Cruz AN, Self SG, Barouch DH. Focus and breadth of cellular immune responses elicited by a heterologous insert prime-boost vaccine regimen in rhesus monkeys. Vaccine. 30: 506-9. PMID 22133509 DOI: 10.1016/J.Vaccine.2011.11.079 |
0.37 |
|
| 2012 |
Huang Y, Self SG, Shao Y. China and HIV vaccine research: An old country with a new commitment Journal of Aids and Clinical Research. 3: 1. DOI: 10.4172/2155-6113.1000E106 |
0.349 |
|
| 2011 |
Gilbert PB, Grove D, Gabriel E, Huang Y, Gray G, Hammer SM, Buchbinder SP, Kublin J, Corey L, Self SG. A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine Regimens. Statistical Communications in Infectious Diseases. 3. PMID 23181167 DOI: 10.2202/1948-4690.1037 |
0.395 |
|
| 2011 |
Li F, Finnefrock AC, Dubey SA, Korber BT, Szinger J, Cole S, McElrath MJ, Shiver JW, Casimiro DR, Corey L, Self SG. Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step study. Plos One. 6: e20479. PMID 21695251 DOI: 10.1371/Journal.Pone.0020479 |
0.406 |
|
| 2011 |
Liu Y, Li F, Liu Y, Hong K, Meng X, Chen J, Zhang Z, Huo Z, Sun M, Self SG, Shao Y. HIV fragment gag vaccine induces broader T cell response in mice. Vaccine. 29: 2582-9. PMID 21292005 DOI: 10.1016/J.Vaccine.2011.01.049 |
0.351 |
|
| 2010 |
Gill DK, Huang Y, Levine GL, Sambor A, Carter DK, Sato A, Kopycinski J, Hayes P, Hahn B, Birungi J, Tarragona-Fiol T, Wan H, Randles M, Cooper AR, Ssemaganda A, ... ... Self SG, et al. Equivalence of ELISpot assays demonstrated between major HIV network laboratories. Plos One. 5: e14330. PMID 21179404 DOI: 10.1371/Journal.Pone.0014330 |
0.413 |
|
| 2010 |
Nicholson O, Dicandilo F, Kublin J, Sun X, Quirk E, Miller M, Gray G, Pape J, Robertson MN, Mehrotra DV, Self S, Turner K, Sanchez J, Pitisuttithum P, Duerr A, et al. Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults. Aids Research and Human Retroviruses. PMID 20854108 DOI: 10.1089/Aid.2010.0151 |
0.374 |
|
| 2010 |
Ribeiro RM, Qin L, Chavez LL, Li D, Self SG, Perelson AS. Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection. Journal of Virology. 84: 6096-102. PMID 20357090 DOI: 10.1128/Jvi.00127-10 |
0.329 |
|
| 2009 |
Hudgens MG, Gilbert PB, Mascola JR, Wu CD, Barouch DH, Self SG. Power to detect the effects of HIV vaccination in repeated low-dose challenge experiments. The Journal of Infectious Diseases. 200: 609-13. PMID 19591571 DOI: 10.1086/600891 |
0.352 |
|
| 2009 |
Barouch DH, Liu J, Lynch DM, O'Brien KL, La Porte A, Simmons NL, Riggs AM, Clark S, Abbink P, Montefiori DC, Landucci G, Forthal DN, Self SG, Carville A, Mansfield K, et al. Protective efficacy of a single immunization of a chimeric adenovirus vector-based vaccine against simian immunodeficiency virus challenge in rhesus monkeys. Journal of Virology. 83: 9584-90. PMID 19553307 DOI: 10.1128/Jvi.00821-09 |
0.344 |
|
| 2009 |
Gilbert PB, Qin L, Self SG. Response to Andrew Dunning's comment on 'evaluating a surrogate endpoint at three levels, with application to vaccine development'. Statistics in Medicine. 28: 716-9. PMID 19140113 DOI: 10.1002/Sim.3503 |
0.327 |
|
| 2009 |
Self S, Li F, Corey L, McElrath J. P17-25. A model for coverage of T-cell HIV vaccines: Where are we and where do we need to be? Retrovirology. 6: P307. DOI: 10.1186/1742-4690-6-S3-P307 |
0.37 |
|
| 2009 |
Qin L, Stacey A, Norris P, Wang P, Borrow P, Self SG. P10-14. Dynamic profiling and correlation analysis of plasma viral load and cytokine and chemokine profiles in acute HIV-1 infection Retrovirology. 6: P145. DOI: 10.1186/1742-4690-6-S3-P145 |
0.332 |
|
| 2009 |
Rolland M, Tovanabutra S, Gilbert PB, Sanders-Buell E, Heath L, deCamp AC, Magaret CC, Bose M, Bradfield A, O'Sullivan A, Crossler J, Deng W, Zhao H, Wong K, Raugi DN, ... ... Self SG, et al. OA06-06 LB. Evidence of vaccine-induced changes in breakthrough HIV-1 strains from the Step trial Retrovirology. 6: O42. DOI: 10.1186/1742-4690-6-S3-O42 |
0.32 |
|
| 2008 |
McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, Janes H, Defawe OD, Carter DK, Hural J, Akondy R, Buchbinder SP, Robertson MN, Mehrotra DV, Self SG, Corey L, et al. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet (London, England). 372: 1894-905. PMID 19012957 DOI: 10.1016/S0140-6736(08)61592-5 |
0.391 |
|
| 2008 |
Tomaras GD, Yates NL, Liu P, Qin L, Fouda GG, Chavez LL, Decamp AC, Parks RJ, Ashley VC, Lucas JT, Cohen M, Eron J, Hicks CB, Liao HX, Self SG, et al. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. Journal of Virology. 82: 12449-63. PMID 18842730 DOI: 10.1128/Jvi.01708-08 |
0.315 |
|
| 2008 |
Morgan C, Marthas M, Miller C, Duerr A, Cheng-Mayer C, Desrosiers R, Flores J, Haigwood N, Hu SL, Johnson RP, Lifson J, Montefiori D, Moore J, Robert-Guroff M, Robinson H, ... Self S, et al. The use of nonhuman primate models in HIV vaccine development. Plos Medicine. 5: e173. PMID 18700814 DOI: 10.1371/Journal.Pmed.0050173 |
0.417 |
|
| 2008 |
Shulman N, Bellew M, Snelling G, Carter D, Huang Y, Li H, Self SG, McElrath MJ, De Rosa SC. Development of an automated analysis system for data from flow cytometric intracellular cytokine staining assays from clinical vaccine trials. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 73: 847-56. PMID 18615598 DOI: 10.1002/Cyto.A.20600 |
0.309 |
|
| 2008 |
Abu-Raddad LJ, Magaret AS, Celum C, Wald A, Longini IM, Self SG, Corey L. Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. Plos One. 3: e2230. PMID 18493617 DOI: 10.1371/Journal.Pone.0002230 |
0.348 |
|
| 2008 |
Sampson JN, Self SG. Identifying trait clusters by linkage profiles: application in genetical genomics. Bioinformatics (Oxford, England). 24: 958-64. PMID 18310620 DOI: 10.1093/Bioinformatics/Btn064 |
0.49 |
|
| 2008 |
Gilbert PB, Qin L, Self SG. Evaluating a surrogate endpoint at three levels, with application to vaccine development. Statistics in Medicine. 27: 4758-78. PMID 17979212 DOI: 10.1002/Sim.3122 |
0.393 |
|
| 2007 |
Qin L, Gilbert PB, Corey L, McElrath MJ, Self SG. A framework for assessing immunological correlates of protection in vaccine trials. The Journal of Infectious Diseases. 196: 1304-12. PMID 17922394 DOI: 10.1086/522428 |
0.369 |
|
| 2007 |
Ackland J, Allen S, Barth-Jones D, Birx D, Chomba E, Churchyard G, Duerr A, Jin S, Johnston M, Fast PE, Fix A, Foulkes M, Follmann D, Hutubessy R, Malone S, ... ... Self S, et al. Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USA Aids. 21: 539-546. PMID 17301582 DOI: 10.1097/Qad.0B013E328011A0C9 |
0.38 |
|
| 2007 |
Dasgupta A, Self SG, Das Gupta S. Non-identifiable parametric probability models and reparametrization Journal of Statistical Planning and Inference. 137: 3380-3393. DOI: 10.1016/J.Jspi.2007.03.018 |
0.453 |
|
| 2006 |
Moodie Z, Huang Y, Gu L, Hural J, Self SG. Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials. Journal of Immunological Methods. 315: 121-32. PMID 16959262 DOI: 10.1016/J.Jim.2006.07.015 |
0.406 |
|
| 2006 |
Qin LX, Self SG. The clustering of regression models method with applications in gene expression data. Biometrics. 62: 526-33. PMID 16918917 DOI: 10.1111/J.1541-0420.2005.00498.X |
0.492 |
|
| 2006 |
Cai T, Gilbert PB, Self SG. Joint inferences on vaccine efficacy against infection and disease with application to the first HIV vaccine efficacy trial Journal of Biopharmaceutical Statistics. 16: 517-538. PMID 16892911 DOI: 10.1080/10543400600719483 |
0.393 |
|
| 2006 |
Li F, Malhotra U, Gilbert PB, Hawkins NR, Duerr AC, McElrath JM, Corey L, Self SG. Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation. Vaccine. 24: 6893-904. PMID 16890329 DOI: 10.1016/J.Vaccine.2006.06.009 |
0.38 |
|
| 2006 |
Wick WD, Gilbert PB, Self SG. On modeling HIV and T cells in vivo: assessing causal estimators in vaccine trials. Plos Computational Biology. 2: e64. PMID 16789816 DOI: 10.1371/Journal.Pcbi.0020064 |
0.419 |
|
| 2006 |
Moodie Z, Rossini AJ, Hudgens MG, Gilbert PB, Self SG, Russell ND. Statistical evaluation of HIV vaccines in early clinical trials. Contemporary Clinical Trials. 27: 147-60. PMID 16426900 DOI: 10.1016/J.Cct.2005.11.008 |
0.39 |
|
| 2005 |
Wick WD, Yang OO, Corey L, Self SG. How many human immunodeficiency virus type 1-infected target cells can a cytotoxic T-lymphocyte kill? Journal of Virology. 79: 13579-86. PMID 16227278 DOI: 10.1128/Jvi.79.21.13579-13586.2005 |
0.346 |
|
| 2005 |
Gilbert PB, Peterson ML, Follmann D, Hudgens MG, Francis DP, Gurwith M, Heyward WL, Jobes DV, Popovic V, Self SG, Sinangil F, Burke D, Berman PW. Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial. The Journal of Infectious Diseases. 191: 666-77. PMID 15688279 DOI: 10.1086/428405 |
0.388 |
|
| 2004 |
Sacks SL, Griffiths PD, Corey L, Cohen C, Cunningham A, Dusheiko GM, Self S, Spruance S, Stanberry LR, Wald A, Whitley RJ. Lessons from HIV and hepatitis viruses. Antiviral Research. S11-8. PMID 15450381 DOI: 10.1016/J.Antiviral.2004.06.003 |
0.347 |
|
| 2004 |
Hudgens MG, Self SG, Chiu YL, Russell ND, Horton H, McElrath MJ. Statistical considerations for the design and analysis of the ELISpot assay in HIV-1 vaccine trials. Journal of Immunological Methods. 288: 19-34. PMID 15183082 DOI: 10.1016/J.Jim.2004.01.018 |
0.396 |
|
| 2004 |
Hudgens MG, Gilbert PB, Self SG. Endpoints in vaccine trials. Statistical Methods in Medical Research. 13: 89-114. PMID 15068256 DOI: 10.1191/0962280204Sm356Ra |
0.342 |
|
| 2003 |
Hudgens MG, Hoering A, Self SG. On the analysis of viral load endpoints in HIV vaccine trials. Statistics in Medicine. 22: 2281-98. PMID 12854093 DOI: 10.1002/Sim.1394 |
0.409 |
|
| 2003 |
Gilbert PB, DeGruttola VG, Hudgens MG, Self SG, Hammer SM, Corey L. What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials. The Journal of Infectious Diseases. 188: 179-93. PMID 12854072 DOI: 10.1086/376449 |
0.401 |
|
| 2002 |
Wick D, Self SG. What's the matter with HIV-directed killer T cells? Journal of Theoretical Biology. 219: 19-31. PMID 12392972 DOI: 10.1006/Jtbi.2002.3103 |
0.358 |
|
| 2002 |
Wick D, Self SG, Corey L. Do scarce targets or T killers control primary HIV infection? Journal of Theoretical Biology. 214: 209-14. PMID 11812173 DOI: 10.1006/Jtbi.2001.2457 |
0.336 |
|
| 2001 |
Berrey MM, Schacker T, Collier AC, Shea T, Brodie SJ, Mayers D, Coombs R, Krieger J, Chun TW, Fauci A, Self SG, Corey L. Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS Journal of Infectious Diseases. 183: 1466-1475. PMID 11319682 DOI: 10.1086/320189 |
0.314 |
|
| 2001 |
Seage GR, Holte SE, Metzger D, Koblin BA, Gross M, Celum C, Marmor M, Woody G, Mayer KH, Stevens C, Judson FN, McKirnan D, Sheon A, Self S, Buchbinder SP. Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. American Journal of Epidemiology. 153: 619-27. PMID 11282787 DOI: 10.1093/Aje/153.7.619 |
0.377 |
|
| 2000 |
Wick D, Self SG. Early HIV infection in vivo: Branching-process model for studying timing of immune responses and drug therapy Mathematical Biosciences. 165: 115-134. PMID 10854614 DOI: 10.1016/S0025-5564(00)00013-4 |
0.351 |
|
| 1998 |
Gilbert PB, Self SG, Ashby MA. Statistical methods for assessing differential vaccine protection against human immunodeficiency virus types Biometrics. 54: 799-814. PMID 9750238 DOI: 10.2307/2533835 |
0.427 |
|
| 1997 |
Wick D, Self SG. Estimating disease attack rates in heterogeneous interacting populations, with applications to HIV vaccine trials Annals of Statistics. 25: 642-661. DOI: 10.1214/Aos/1031833667 |
0.392 |
|
| 1995 |
Schaper C, Fleming TR, Self SG, Rida WN. Statistical issues in the design of HIV vaccine trials Annual Review of Public Health. 16: 1-22. PMID 7639865 DOI: 10.1146/Annurev.Pu.16.050195.000245 |
0.39 |
|
| Show low-probability matches. |